An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

T. E. Witzig, J. M. Vose, P. L. Zinzani, C. B. Reeder, R. Buckstein, J. A. Polikoff, R. Bouabdallah, C. Haioun, H. Tilly, P. Guo, D. Pietronigro, A. L. Ervin-Haynes, M. S. Czuczman

Research output: Contribution to journalArticlepeer-review

314 Scopus citations

Fingerprint

Dive into the research topics of 'An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences